• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特异质性药物反应:反应性代谢物综合征

Idiosyncratic drug reactions: the reactive metabolite syndromes.

作者信息

Knowles S R, Uetrecht J, Shear N H

机构信息

Department of Medicine, Sunnybrook & Women's College Health Sciences Centre, University of Toronto, Ontario, Canada.

出版信息

Lancet. 2000 Nov 4;356(9241):1587-91. doi: 10.1016/S0140-6736(00)03137-8.

DOI:10.1016/S0140-6736(00)03137-8
PMID:11075787
Abstract

Idiosyncratic drug reactions are unpredictable reactions that can result in significant morbidity and mortality. Severe reactions are often characterised by fever and internal organ involvement. Despite progress in the identification of reactive metabolites believed to be the cause of idiosyncratic reactions, the basic mechanisms remain elusive. Furthermore, because of the lack of consensus regarding definition of these syndromes, reporting, and therefore epidemiological data, are often unreliable. Research is needed to explore further the pathophysiology of these reactions, so that better diagnostic tests and treatment methods can be developed.

摘要

特异质药物反应是不可预测的反应,可导致严重的发病率和死亡率。严重反应通常以发热和内脏器官受累为特征。尽管在确定被认为是特异质反应原因的反应性代谢产物方面取得了进展,但其基本机制仍然难以捉摸。此外,由于对这些综合征的定义缺乏共识,报告以及因此的流行病学数据往往不可靠。需要开展研究以进一步探索这些反应的病理生理学,从而开发出更好的诊断测试和治疗方法。

相似文献

1
Idiosyncratic drug reactions: the reactive metabolite syndromes.特异质性药物反应:反应性代谢物综合征
Lancet. 2000 Nov 4;356(9241):1587-91. doi: 10.1016/S0140-6736(00)03137-8.
2
Adverse drug reactions.药物不良反应
Compr Ther. 1980 Apr;6(4):22-30.
3
Drug metabolism by leukocytes and its role in drug-induced lupus and other idiosyncratic drug reactions.白细胞的药物代谢及其在药物性狼疮和其他特异质性药物反应中的作用。
Crit Rev Toxicol. 1990;20(4):213-35. doi: 10.3109/10408449009089863.
4
Reactive metabolites and adverse drug reactions: clinical considerations.反应性代谢产物与药物不良反应:临床考量
Clin Rev Allergy Immunol. 2003 Jun;24(3):229-38. doi: 10.1385/CRIAI:24:3:229.
5
The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions.白细胞产生的反应性代谢产物在特异质药物反应发病机制中的作用。
Drug Metab Rev. 1992;24(3):299-366. doi: 10.3109/03602539208996297.
6
The role of reactive drug metabolites in immune-mediated adverse drug reactions.反应性药物代谢产物在免疫介导的药物不良反应中的作用。
Ann Pharmacother. 1997 Nov;31(11):1378-87. doi: 10.1177/106002809703101116.
7
Allergy and adverse drug reactions.
J Am Acad Dermatol. 1982 May;6(5):833-45. doi: 10.1016/s0190-9622(82)70073-8.
8
Management of drug allergy.药物过敏的管理。
Mod Treat. 1968 Sep;5(5):792-813.
9
Allergic and hypersensitivity reactions in the intensive care unit.重症监护病房中的过敏和超敏反应。
Crit Care Med. 2010 Jun;38(6 Suppl):S162-8. doi: 10.1097/CCM.0b013e3181de0c99.
10
Prediction of a new drug's potential to cause idiosyncratic reactions.预测一种新药引发特异反应的可能性。
Curr Opin Drug Discov Devel. 2001 Jan;4(1):55-9.

引用本文的文献

1
NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic Cohort.NAT2乙酰化状态可预测抗结核治疗期间的肝毒性:多民族队列的累积风险分析
Int J Mol Sci. 2025 Apr 19;26(8):3881. doi: 10.3390/ijms26083881.
2
Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury.药物与尿苷二磷酸葡萄糖醛酸转移酶(UGT)的相互作用是药物性肝损伤的一个预测指标。
Hepatology. 2025 May 1;81(5):1512-1521. doi: 10.1097/HEP.0000000000001007. Epub 2024 Jul 17.
3
Microphysiological Models for Mechanistic-Based Prediction of Idiosyncratic DILI.
基于机制的药物性肝损伤个体化预测的微生理模型。
Cells. 2023 May 25;12(11):1476. doi: 10.3390/cells12111476.
4
The role of testing in pharmacovigilance for ß-lactam-induced serum sickness-like reaction: A pilot study.检测在β-内酰胺诱导的血清病样反应药物警戒中的作用:一项试点研究。
Front Pharmacol. 2022 Aug 30;13:945545. doi: 10.3389/fphar.2022.945545. eCollection 2022.
5
Characterization of reactive intermediates formation in dacomitinib metabolism and bioactivation pathways elucidation by LC-MS/MS: phase I metabolic investigation.通过液相色谱-串联质谱法表征达可替尼代谢过程中反应中间体的形成并阐明生物活化途径:I期代谢研究
RSC Adv. 2018 Nov 19;8(68):38733-38744. doi: 10.1039/c8ra06709k. eCollection 2018 Nov 16.
6
LC-ESI-MS/MS reveals the formation of reactive intermediates in brigatinib metabolism: elucidation of bioactivation pathways.液相色谱-电喷雾串联质谱法揭示了布加替尼代谢过程中反应性中间体的形成:生物活化途径的阐明。
RSC Adv. 2018 Jan 3;8(3):1182-1190. doi: 10.1039/c7ra10533a. eCollection 2018 Jan 2.
7
Sapitinib: reactive intermediates and bioactivation pathways characterized by LC-MS/MS.沙匹替尼:通过液相色谱-串联质谱法表征的反应中间体和生物活化途径
RSC Adv. 2019 Oct 16;9(57):32995-33006. doi: 10.1039/c9ra03926k. eCollection 2019 Oct 15.
8
Reactive intermediates in naquotinib metabolism identified by liquid chromatography-tandem mass spectrometry: phase I metabolic profiling.通过液相色谱-串联质谱法鉴定的那喹替尼代谢中的反应性中间体:I 相代谢谱分析。
RSC Adv. 2019 Apr 1;9(18):10211-10225. doi: 10.1039/c9ra00224c. eCollection 2019 Mar 28.
9
Reactive intermediates in copanlisib metabolism identified by LC-MS/MS: phase I metabolic profiling.通过液相色谱-串联质谱法鉴定的库潘尼西代谢中的反应性中间体:I期代谢谱分析。
RSC Adv. 2019 Feb 21;9(11):6409-6418. doi: 10.1039/c8ra10322d. eCollection 2019 Feb 18.
10
and metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling.瑞博西尼的代谢:一种用于阐明生物活化途径和代谢物谱分析的质谱方法。
RSC Adv. 2020 Jun 12;10(38):22668-22683. doi: 10.1039/d0ra01624a. eCollection 2020 Jun 10.